Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Gorse · SciRah

Researcher profile · Semantic Scholar

G. Gorse

Share profile

G. Gorse — researcher profile on SciRah

h-index: 41
Works: 106
Citations: 5,718

Most-cited papers

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.
J. Mascola, S. Snyder, O. Weislow, Seifu M. Belay +13 more
1996Journal of Infectious Diseases471 citations Open access
Semantic Scholar
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.
K. Nichol, P. Mendelman, K. Mallon, L. Jackson +4 more
1999Journal of the American Medical Association (JAMA)430 citations
Semantic Scholar
N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial.
L. Radonovich, M. Simberkoff, M. Bessesen, Alexandria C. Brown +11 more
2019Journal of the American Medical Association (JAMA)403 citations Open access
Semantic Scholar
Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older.
A. Falsey, J. Treanor, N. Tornieporth, J. Capellan +1 more
2009Journal of Infectious Diseases387 citations Open access
Semantic Scholar
Induction of immune responses to HIV‐1 by canarypox virus (ALVAC) HIV‐1 and gp120 SF‐2 recombinant vaccines in uninfected volunteers
R. Belshe, G. Gorse, M. Mulligan, Thomas G. Evans +10 more
1998AIDS (London)180 citations Open access
Semantic Scholar
Prevalence of Antibodies to Four Human Coronaviruses Is Lower in Nasal Secretions than in Serum
G. Gorse, Gira B. Patel, Joseph N. Vitale, T. O'Connor
2010Clinical and Vaccine Immunology168 citations Open access
Semantic Scholar
Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers.
R. Belshe, C. Stevens, G. Gorse, S. Buchbinder +22 more
2001Journal of Infectious Diseases155 citations Open access
Semantic Scholar
The Safety and Immunogenicity of a Human Immunodeficiency Virus Type 1 (HIV-1) Recombinant gp160 Candidate Vaccine in Humans
R. Dolin, B. Graham, S. Greenberg, C. Tacket +13 more
1991151 citations
Semantic Scholar
Augmentation of Human Immunodeficiency Virus Type 1 Neutralizing Antibody by Priming with gp160 Recombinant Vaccinia and Boosting with gp160 in Vaccinia-Naive Adults
B. Graham, T. Matthews, R. Belshe, M. L. Clements +6 more
1993150 citations
Semantic Scholar
Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus‐associated illnesses
G. Gorse, M. M. Donovan, Gira B. Patel
2020Journal of Medical Virology136 citations Open access
Semantic Scholar
Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors.
L. Jackson, Glenn Austin, Robert T. Chen, R. Stout +5 more
2001Vaccine135 citations
Semantic Scholar
Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network.
B. Graham, R. Belshe, M. L. Clements, R. Dolin +16 more
1992Journal of Infectious Diseases126 citations
Semantic Scholar
Neutralizing Antibodies to HIV-1 in Seronegative Volunteers Immunized With Recombinant gp 120 From the MN Strain of HIV-1
R. Belshe, B. Graham, M. Keefer, G. Gorse +13 more
1994117 citations
Semantic Scholar
Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccine.
David H. Schwartz, M. Clements, G. Gorse, R. Belshe +8 more
1993The Lancet116 citations Open access
Semantic Scholar
Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial.
G. Gorse, W. Keitel, H. Keyserling, D. Taylor +5 more
2006Vaccine101 citations
Semantic Scholar
Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals.
A. Falsey, E. Walsh, J. Capellan, S. Gravenstein +11 more
2008Journal of Infectious Diseases93 citations Open access
Semantic Scholar
Safety and Immunogenicity of a High‐Titered Canarypox Vaccine in Combination With rgp120 in a Diverse Population of HIV‐1‐Uninfected Adults: AIDS Vaccine Evaluation Group Protocol 022A
K. Gupta, M. Hudgens, L. Corey, J. Mcelrath +13 more
2002Journal of Acquired Immune Deficiency Syndromes92 citations Open access
Semantic Scholar
Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network.
R. Belshe, B. S. Graham, M. Keefer, G. Gorse +6 more
1994Journal of the American Medical Association (JAMA)89 citations
Semantic Scholar
Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group.
B. Graham, M. McElrath, R. Connor, D. Schwartz +15 more
1998Journal of Infectious Diseases86 citations Open access
Semantic Scholar
Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine.
G. Gorse, M. J. Campbell, Esther E. Otto, D. Powers +2 more
1995Journal of Infectious Diseases86 citations
Semantic Scholar
Immunogenicity and safety of Fluzone(®) intradermal and high-dose influenza vaccines in older adults ≥65 years of age: a randomized, controlled, phase II trial.
P. Tsang, G. Gorse, Cynthia B Strout, M. Sperling +4 more
2014Vaccine85 citations Open access
Semantic Scholar
Safety and Immunogenicity of a Candidate HIV-1 Vaccine in Healthy Adults: Recombinant Glycoprotein (rgp) 120: A Randomized, Double-Blind Trial
B. Graham, M. Keefer, M. McElrath, G. Gorse +6 more
1996Annals of Internal Medicine82 citations
Semantic Scholar
Safety and Immunogenicity of a Fully Glycosylated Recombinant gp160 Human Immunodeficiency Virus Type 1 Vaccine in Subjects at Low Risk of Infection
R. Belshe, M. L. Clements, R. Dolin, B. Graham +13 more
199382 citations
Semantic Scholar
Genetic and immunologic characterization of viruses infecting MN-rgp120-vaccinated volunteers.
P. Berman, Alane M. Gray, T. Wrin, J. Vennari +5 more
1997Journal of Infectious Diseases81 citations Open access
Semantic Scholar
Cytotoxic T Cell and Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 Envelope with a Combination Vaccine Regimen
L. Corey, M. McElrath, K. Weinhold, T. Matthews +5 more
199875 citations Open access
Semantic Scholar
Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with rgp120.
L. Corey, M. Mulligan, P. Goepfert, S. Sabbaj +26 more
2001Journal of Infectious Diseases70 citations Open access
Semantic Scholar
A Phase II Study of Two HIV Type 1 Envelope Vaccines, Comparing Their Immunogenicity in Populations at Risk for Acquiring HIV Type 1 Infection
M. McElrath, L. Corey, D. Montefiori, M. Wolff +15 more
2000AIDS Research and Human Retroviruses70 citations
Semantic Scholar
Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly.
G. Gorse, Esther E. Otto, D. Powers, G. W. Chambers +2 more
1996Journal of Infectious Diseases67 citations Open access
Semantic Scholar
Recruitment and Baseline Epidemiologic Profile of Participants in the First Phase 3 HIV Vaccine Efficacy Trial
Clayton D. Harro, F. Judson, G. Gorse, K. Mayer +6 more
2004Journal of Acquired Immune Deficiency Syndromes63 citations Open access
Semantic Scholar
Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study.
G. Gorse, T. O'Connor, Stephen L Young, P. Mendelman +14 more
2003Vaccine63 citations
Semantic Scholar
Infection Control Practices in Gastrointestinal Endoscopy in the United States: A National Survey
G. Gorse, R. Messner
1991Infection Control & Hospital Epidemiology62 citations
Semantic Scholar
Human Coronavirus and Acute Respiratory Illness in Older Adults with Chronic Obstructive Pulmonary Disease
G. Gorse, T. O'Connor, S. L. Hall, Joseph N. Vitale +1 more
2009Journal of Infectious Diseases61 citations Open access
Semantic Scholar
Recognizing influenza in older patients with chronic obstructive pulmonary disease who have received influenza vaccine.
K. Neuzil, T. O'Connor, G. Gorse, K. Nichol
2003Clinical Infectious Diseases60 citations
Semantic Scholar
A Dose-Ranging Study of a Prototype Synthetic HIV-1MN V3 Branched Peptide Vaccine
G. Gorse, M. Keefer, R. Belshe, T. Matthews +9 more
199658 citations Open access
Semantic Scholar
Protecting Healthcare Personnel in Outpatient Settings: The Influence of Mandatory Versus Nonmandatory Influenza Vaccination Policies on Workplace Absenteeism During Multiple Respiratory Virus Seasons
J. Frederick, Alexandria C. Brown, D. Cummings, C. Gaydos +11 more
2018Infection Control & Hospital Epidemiology57 citations Open access
Semantic Scholar
Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults.
G. Gorse, L. Baden, M. Wecker, M. Newman +7 more
2008Vaccine57 citations
Semantic Scholar
Superiority of live attenuated compared with inactivated influenza A virus vaccines in older, chronically ill adults.
G. Gorse, R. Belshe, N. Munn
1991Chest51 citations
Semantic Scholar
Immunity to influenza in older adults with chronic obstructive pulmonary disease.
G. Gorse, T. O'Connor, Frances K. Newman, Mahendra D. Mandava +3 more
2004Journal of Infectious Diseases50 citations Open access
Semantic Scholar
HIV-1MN Recombinant Glycoprotein 160 Vaccine-Induced Cellular and Humoral Immunity Boosted by HIV-1MN Recombinant Glycoprotein 120 Vaccine
G. Gorse, L. Corey, Gira B. Patel, Mahendra D. Mandava +7 more
1999AIDS Research and Human Retroviruses45 citations
Semantic Scholar
Impact of a winter respiratory virus season on patients with COPD and association with influenza vaccination.
G. Gorse, T. O'Connor, Stephen L Young, M. P. Habib +3 more
2006Chest41 citations
Semantic Scholar
Safety and immunogenicity of a quadrivalent intradermal influenza vaccine in adults.
G. Gorse, A. Falsey, A. Ozol-Godfrey, V. Landolfi +1 more
2015Vaccine38 citations
Semantic Scholar
The Respiratory Protection Effectiveness Clinical Trial (ResPECT): a cluster-randomized comparison of respirator and medical mask effectiveness against respiratory infections in healthcare personnel
L. Radonovich, M. Bessesen, D. Cummings, Aaron E. Eagan +10 more
2016BMC Infectious Diseases35 citations Open access
Semantic Scholar
Canarypox Vaccines Induce Antigen-Specific Human γδ T Cells Capable of Interferon-γ Production
S. Worku, G. Gorse, R. Belshe, D. Hoft
200135 citations Open access
Semantic Scholar
Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network.
B. Graham, T. Matthews, R. Belshe, M. L. Clements +6 more
1993Journal of Infectious Diseases35 citations
Semantic Scholar
Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age.
G. Gorse, A. Falsey, J. Fling, Terry L. Poling +2 more
2013Vaccine34 citations
Semantic Scholar
Lymphocyte proliferative responses following immunization with human immunodeficiency virus recombinant GP160. The NIAID AIDS Vaccine Clinical Trials Network.
G. Gorse, R. Belshe, Frances K. Newman, S. Frey
1992Vaccine34 citations
Semantic Scholar
Comparison of the immune response to recombinant gp120 in humans and chimpanzees
P. Berman, D. Eastman, D. Wilkes, G. Nakamura +6 more
1994AIDS (London)31 citations
Semantic Scholar
Anaerobic endocarditis caused by Staphylococcus saccharolyticus
T. Westblom, G. Gorse, T. Milligan, A. Schindzielorz
1990Journal of Clinical Microbiology28 citations Open access
Semantic Scholar
Association of Malnutrition with Nosocomial Infection
G. Gorse, R. Messner, N. Stephens
1989Infection Control & Hospital Epidemiology25 citations
Semantic Scholar
DNA and Modified Vaccinia Virus Ankara Vaccines Encoding Multiple Cytotoxic and Helper T-Lymphocyte Epitopes of Human Immunodeficiency Virus Type 1 (HIV-1) Are Safe but Weakly Immunogenic in HIV-1-Uninfected, Vaccinia Virus-Naive Adults
G. Gorse, M. Newman, A. deCamp, C. Hay +6 more
2012Clinical and Vaccine Immunology24 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Belshe×18
Invite
R. Belshe — researcher profile on SciRah
M. Keefer×15
Invite
M. Keefer — researcher profile on SciRah
B. Graham×12
Invite
B. Graham — researcher profile on SciRah
R. Dolin×11
Invite
R. Dolin — researcher profile on SciRah

×10

Invite

K. Weinhold — researcher profile on SciRah

Invite

P. Wright — researcher profile on SciRah

Invite

T. Matthews — researcher profile on SciRah

Invite

D. Schwartz — researcher profile on SciRah

M. L. Clements×7

Invite

M. L. Clements — researcher profile on SciRah

D. Montefiori×7

Invite

D. Montefiori — researcher profile on SciRah

Invite

D. Stablein — researcher profile on SciRah

Invite

K. Nichol — researcher profile on SciRah